Is Progressive (PGR) a Buy as Wall Street Analysts Look Optimistic?
Werte in diesem Artikel
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Progressive (PGR).Progressive currently has an average brokerage recommendation (ABR) of 1.91, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 22 brokerage firms. An ABR of 1.91 approximates between Strong Buy and Buy.Of the 22 recommendations that derive the current ABR, 11 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 50% and 9.1% of all recommendations.Brokerage Recommendation Trends for PGRCheck price target & stock forecast for Progressive here>>>While the ABR calls for buying Progressive, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.Should You Invest in PGR?Looking at the earnings estimate revisions for Progressive, the Zacks Consensus Estimate for the current year has increased 4.4% over the past month to $16.88.Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Progressive. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Progressive may serve as a useful guide for investors.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Progressive Corporation (PGR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Progressive und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Progressive
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Progressive
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Progressive Corp.
Analysen zu Progressive Corp.
Datum | Rating | Analyst | |
---|---|---|---|
13.06.2019 | Progressive Buy | B. Riley FBR | |
09.01.2019 | Progressive Overweight | Barclays Capital | |
11.12.2018 | Progressive Buy | B. Riley FBR | |
11.07.2017 | Progressive Mkt Perform | FBR & Co. | |
18.05.2017 | Progressive Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
13.06.2019 | Progressive Buy | B. Riley FBR | |
09.01.2019 | Progressive Overweight | Barclays Capital | |
11.12.2018 | Progressive Buy | B. Riley FBR | |
30.04.2015 | Progressive Buy | UBS AG | |
18.06.2012 | Progressive overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
11.07.2017 | Progressive Mkt Perform | FBR & Co. | |
18.05.2017 | Progressive Hold | Deutsche Bank AG | |
10.05.2017 | Progressive Mkt Perform | FBR & Co. | |
03.04.2017 | Progressive Mkt Perform | FBR & Co. | |
18.04.2011 | Progressive equal-weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
19.09.2016 | Progressive Sell | Deutsche Bank AG | |
17.03.2016 | Progressive Sell | Deutsche Bank AG | |
20.07.2015 | Progressive Sell | Deutsche Bank AG | |
18.09.2007 | Progressive sell | UBS AG | |
18.01.2007 | Update Progressive Corp.: Sell | Goldman Sachs |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Progressive Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen